Journal
SOUTH AFRICAN JOURNAL OF BOTANY
Volume 143, Issue -, Pages 443-448Publisher
ELSEVIER
DOI: 10.1016/j.sajb.2021.07.043
Keywords
Citronellal; Ornithine decarboxylase; FaDu; HEK-293; anticancer; monoterpene
Categories
Funding
- Council of Scientific and Industrial Research Aroma Mission Project [HCP 007]
Ask authors/readers for more resources
Citronellal exhibits antiproliferative effects on hypopharyngeal carcinoma cells by suppressing ornithine decarboxylase activity, while being non-toxic to normal cells. It shows potential as a prototype for designing new ODC inhibitors.
Citronellal, an acyclic monoterpene with an aldehyde group, is present in many plants, including species of Eucalyptus, Corymbia, Cymbopogon, Coriandrum. It is also known as rhodinol and possesses strong insect repellant and antifungal properties. In this study, we investigated the antiproliferative action of citronellal on hypopharyngeal carcinoma (FaDu) and normal (HEK-293) cell lines. Citronellal suppresses the activity of ornithine decarboxylase (ODC: 77.12 +/- 10.73 mu M) and inhibits the proliferation of FaDu cells with an IC50 of 71.81 +/- 3.37 mu M. The qRT-expression analysis depicts citronellal down-regulate the expression of ODC, and a robust binding interaction of citronellal with ODC was observed in molecular docking studies. Further, it also arrests the G2/M phase of FaDu cells, followed by an increase in the number of sub-diploid cells but was non-toxic to normal cell line. The toxicity prediction studies revealed citronellal follows the Lipinski rule of 5 and the Ghose rule. These observations provide experimental evidence for citronellal to be used as a new prototype for designing ODC inhibitors. (C) 2021 SAAB. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available